RECRUITING

Mind Body Intervention for Chronic Migraine Headaches

Talk to us

Conditions

MigrainesChronic PainHeadaches

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Official Title

Mind Body Intervention for Chronic Migraine Headaches

Quick Facts

Study Start:2024-11-15
Study Completion:2026-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06690060

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adult (≥ 18 years of age)
  2. 2. Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91
  3. 3. A score of ≥ 50 on the Headache Impact Test-6 self-report survey (moderate impact) 92
  4. 4. Presence of migraine headaches at least 5 days per month
  5. 5. Willing to engage in a Mind-Body intervention
  6. 6. Willing/able to participate in remote sessions
  1. 1. Known history or suspicion of headaches due to organic cause (e.g. cancer, sinus infection, head trauma, cerebrovascular disease)
  2. 2. Diagnosis of other chronic pain syndromes that may cloud assessments (e.g. fibromyalgia, chronic idiopathic neck pain)
  3. 3. Diagnosis of cognitive impairment or dementia
  4. 4. Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation
  5. 5. Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered exclusions.

Contacts and Locations

Study Contact

Samuel Kukler
CONTACT
617-754-2882
skukler@bidmc.harvard.edu
Masumi Prasad
CONTACT
617-754-2882
mprasad2@bidmc.harvard.edu

Principal Investigator

Michael Donnino, MD
PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center

Study Locations (Sites)

Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Beth Israel Deaconess Medical Center

  • Michael Donnino, MD, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconess Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-15
Study Completion Date2026-11

Study Record Updates

Study Start Date2024-11-15
Study Completion Date2026-11

Terms related to this study

Keywords Provided by Researchers

  • Migraines
  • Headaches
  • Chronic Pain

Additional Relevant MeSH Terms

  • Migraines
  • Chronic Pain